MKI67 and liver cancer: We found that Ki67 labeling index for tumor cells was significantly lower in the PPP2R3A knockdown (shRNA1) group than in the control group (P = .025; Figure 5C), demonstrating that the knockdown of PPP2R3A inhibited the proliferation of the liver cancer cells in vivo.